# A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease

> **NCT01396213** · PHASE2 · COMPLETED · sponsor: **9 Meters Biopharma, Inc.** · enrollment: 342 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **DRUG:** Larazotide Acetate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01396213
- **Lead sponsor:** 9 Meters Biopharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-07
- **Primary completion:** 2013-08-20
- **Final completion:** 2013-08-20
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2017-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01396213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01396213, "A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01396213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*